BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37368111)

  • 21. Radiomics in colorectal cancer patients.
    Inchingolo R; Maino C; Cannella R; Vernuccio F; Cortese F; Dezio M; Pisani AR; Giandola T; Gatti M; Giannini V; Ippolito D; Faletti R
    World J Gastroenterol; 2023 May; 29(19):2888-2904. PubMed ID: 37274803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is Our Science Representative? A Systematic Review of Racial and Ethnic Diversity in Orthopaedic Clinical Trials from 2000 to 2020.
    Cwalina TB; Jella TK; Manyak GA; Kuo A; Kamath AF
    Clin Orthop Relat Res; 2022 May; 480(5):848-858. PubMed ID: 34855650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A computed tomography-based radiomics nomogram for predicting overall survival in patients with connective tissue disease-associated interstitial lung disease.
    Qin S; Kang B; Liu H; Ji C; Li H; Zhang J; Wang X
    Eur J Radiol; 2023 Aug; 165():110963. PubMed ID: 37437436
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development and Validation of a Computed Tomography-Based Radiomics Signature to Predict Response to Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer.
    Wang W; Peng Y; Feng X; Zhao Y; Seeruttun SR; Zhang J; Cheng Z; Li Y; Liu Z; Zhou Z
    JAMA Netw Open; 2021 Aug; 4(8):e2121143. PubMed ID: 34410397
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cone-beam computed tomography-based delta-radiomics for early response assessment in radiotherapy for locally advanced lung cancer.
    Shi L; Rong Y; Daly M; Dyer B; Benedict S; Qiu J; Yamamoto T
    Phys Med Biol; 2020 Jan; 65(1):015009. PubMed ID: 31307024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a computed tomography-based radiomics nomogram for prediction of transarterial chemoembolization refractoriness in hepatocellular carcinoma.
    Niu XK; He XF
    World J Gastroenterol; 2021 Jan; 27(2):189-207. PubMed ID: 33510559
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcome prediction in resectable lung adenocarcinoma patients: value of CT radiomics.
    Choe J; Lee SM; Do KH; Kim S; Choi S; Lee JG; Seo JB
    Eur Radiol; 2020 Sep; 30(9):4952-4963. PubMed ID: 32356158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic analysis and risk stratification of lung adenocarcinoma undergoing EGFR-TKI therapy with time-serial CT-based radiomics signature.
    Zhang X; Lu B; Yang X; Lan D; Lin S; Zhou Z; Li K; Deng D; Peng P; Zeng Z; Long L
    Eur Radiol; 2023 Feb; 33(2):825-835. PubMed ID: 36166088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CT radiomics compared to a clinical model for predicting checkpoint inhibitor treatment outcomes in patients with advanced melanoma.
    Ter Maat LS; van Duin IAJ; Elias SG; Leiner T; Verhoeff JJC; Arntz ERAN; Troenokarso MF; Blokx WAM; Isgum I; de Wit GA; van den Berkmortel FWPJ; Boers-Sonderen MJ; Boomsma MF; van den Eertwegh FJM; de Groot JWB; Piersma D; Vreugdenhil A; Westgeest HM; Kapiteijn E; van Diest PJ; Pluim JPW; de Jong PA; Suijkerbuijk KPM; Veta M
    Eur J Cancer; 2023 May; 185():167-177. PubMed ID: 36996627
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nomogram Using CT Radiomics Features for Differentiation of Pneumonia-Type Invasive Mucinous Adenocarcinoma and Pneumonia: Multicenter Development and External Validation Study.
    Yu X; Zhang S; Xu J; Huang Y; Luo H; Huang C; Nie P; Deng Y; Mao N; Zhang R; Gao L; Li S; Kang B; Wang X
    AJR Am J Roentgenol; 2023 Feb; 220(2):224-234. PubMed ID: 36102726
    [No Abstract]   [Full Text] [Related]  

  • 31. A short-term follow-up CT based radiomics approach to predict response to immunotherapy in advanced non-small-cell lung cancer.
    Gong J; Bao X; Wang T; Liu J; Peng W; Shi J; Wu F; Gu Y
    Oncoimmunology; 2022; 11(1):2028962. PubMed ID: 35096486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Delta-Radiomics Predicts Response to First-Line Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients with Liver Metastases.
    Giannini V; Pusceddu L; Defeudis A; Nicoletti G; Cappello G; Mazzetti S; Sartore-Bianchi A; Siena S; Vanzulli A; Rizzetto F; Fenocchio E; Lazzari L; Bardelli A; Marsoni S; Regge D
    Cancers (Basel); 2022 Jan; 14(1):. PubMed ID: 35008405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of computed tomography radiomics features in patients with gastric cancer following curative resection.
    Li W; Zhang L; Tian C; Song H; Fang M; Hu C; Zang Y; Cao Y; Dai S; Wang F; Dong D; Wang R; Tian J
    Eur Radiol; 2019 Jun; 29(6):3079-3089. PubMed ID: 30519931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Demographic diversity of US-based participants in GSK-sponsored interventional clinical trials.
    Reid MM; Davis SP; Henry ON; Mathew AA; McCallister S; Nero TT; Rabheru SA; Sampson SH; Vanderslice TF; Williams DT
    Clin Trials; 2023 Apr; 20(2):133-144. PubMed ID: 36744680
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiomics analysis of contrast-enhanced CT predicts lymphovascular invasion and disease outcome in gastric cancer: a preliminary study.
    Chen X; Yang Z; Yang J; Liao Y; Pang P; Fan W; Chen X
    Cancer Imaging; 2020 Apr; 20(1):24. PubMed ID: 32248822
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Computed Tomography-Based Delta-Radiomics Analysis for Discriminating Radiation Pneumonitis in Patients With Esophageal Cancer After Radiation Therapy.
    Wang L; Gao Z; Li C; Sun L; Li J; Yu J; Meng X
    Int J Radiat Oncol Biol Phys; 2021 Oct; 111(2):443-455. PubMed ID: 33974887
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiomics to predict outcomes and abscopal response of patients with cancer treated with immunotherapy combined with radiotherapy using a validated signature of CD8 cells.
    Sun R; Sundahl N; Hecht M; Putz F; Lancia A; Rouyar A; Milic M; Carré A; Battistella E; Alvarez Andres E; Niyoteka S; Romano E; Louvel G; Durand-Labrunie J; Bockel S; Bahleda R; Robert C; Boutros C; Vakalopoulou M; Paragios N; Frey B; Soria JC; Massard C; Ferté C; Fietkau R; Ost P; Gaipl U; Deutsch E
    J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33188037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiomic signature based on CT imaging to distinguish invasive adenocarcinoma from minimally invasive adenocarcinoma in pure ground-glass nodules with pleural contact.
    Jiang Y; Che S; Ma S; Liu X; Guo Y; Liu A; Li G; Li Z
    Cancer Imaging; 2021 Jan; 21(1):1. PubMed ID: 33407884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Computed Tomography-Based Radiomics Analysis for Prediction of Response to Neoadjuvant Chemotherapy in Breast Cancer Patients.
    Duan Y; Yang G; Miao W; Song B; Wang Y; Yan L; Wu F; Zhang R; Mao Y; Wang Z
    J Comput Assist Tomogr; 2023 Mar-Apr 01; 47(2):199-204. PubMed ID: 36790871
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiomics signature of computed tomography imaging for prediction of survival and chemotherapeutic benefits in gastric cancer.
    Jiang Y; Chen C; Xie J; Wang W; Zha X; Lv W; Chen H; Hu Y; Li T; Yu J; Zhou Z; Xu Y; Li G
    EBioMedicine; 2018 Oct; 36():171-182. PubMed ID: 30224313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.